218 related articles for article (PubMed ID: 20236534)
1. Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.
Marcellini S; Bruna C; Henríquez JP; Albistur M; Reyes AE; Barriga EH; Henríquez B; Montecino M
BMC Evol Biol; 2010 Mar; 10():78. PubMed ID: 20236534
[TBL] [Abstract][Full Text] [Related]
2. Crystallization and preliminary X-ray analysis of a domain in the Runx2 transcription factor that interacts with the 1alpha,25 dihydroxy vitamin D3 receptor.
Bruna C; Arriagada G; Lian JB; Stein GS; Bunster M; Martinez-Oyanedel J; Montecino M
J Cell Biochem; 2007 Jun; 101(3):785-9. PubMed ID: 17226779
[TBL] [Abstract][Full Text] [Related]
3. Identification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing osteocalcin gene expression in vitro.
Pinto JP; Conceição NM; Viegas CS; Leite RB; Hurst LD; Kelsh RN; Cancela ML
J Bone Miner Res; 2005 Aug; 20(8):1440-53. PubMed ID: 16007341
[TBL] [Abstract][Full Text] [Related]
4. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
5. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
Paredes R; Arriagada G; Cruzat F; Villagra A; Olate J; Zaidi K; van Wijnen A; Lian JB; Stein GS; Stein JL; Montecino M
Mol Cell Biol; 2004 Oct; 24(20):8847-61. PubMed ID: 15456860
[TBL] [Abstract][Full Text] [Related]
6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
7. Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2.
Funato N; Chapman SL; McKee MD; Funato H; Morris JA; Shelton JM; Richardson JA; Yanagisawa H
Development; 2009 Feb; 136(4):615-25. PubMed ID: 19144722
[TBL] [Abstract][Full Text] [Related]
8. Possible roles of Runx1 and Sox9 in incipient intramembranous ossification.
Yamashiro T; Wang XP; Li Z; Oya S; Aberg T; Fukunaga T; Kamioka H; Speck NA; Takano-Yamamoto T; Thesleff I
J Bone Miner Res; 2004 Oct; 19(10):1671-7. PubMed ID: 15355562
[TBL] [Abstract][Full Text] [Related]
9. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
[TBL] [Abstract][Full Text] [Related]
11. Skeletogenesis in Xenopus tropicalis: characteristic bone development in an anuran amphibian.
Miura S; Hanaoka K; Togashi S
Bone; 2008 Nov; 43(5):901-9. PubMed ID: 18692165
[TBL] [Abstract][Full Text] [Related]
12. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
Peleg S; Ismail A; Uskokovic MR; Avnur Z
J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
[TBL] [Abstract][Full Text] [Related]
13. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease.
Sato S; Kimura A; Ozdemir J; Asou Y; Miyazaki M; Jinno T; Ae K; Liu X; Osaki M; Takeuchi Y; Fukumoto S; Kawaguchi H; Haro H; Shinomiya K; Karsenty G; Takeda S
Arthritis Rheum; 2008 Sep; 58(9):2764-75. PubMed ID: 18759297
[TBL] [Abstract][Full Text] [Related]
14. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.
Shen Q; Christakos S
J Biol Chem; 2005 Dec; 280(49):40589-98. PubMed ID: 16195230
[TBL] [Abstract][Full Text] [Related]
15. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1.
Drissi H; Pouliot A; Stein JL; van Wijnen AJ; Stein GS; Lian JB
J Cell Biochem; 2002; 86(2):403-12. PubMed ID: 12112009
[TBL] [Abstract][Full Text] [Related]
18. Advances in Runx2 regulation and its isoforms.
Li YL; Xiao ZS
Med Hypotheses; 2007; 68(1):169-75. PubMed ID: 16901655
[TBL] [Abstract][Full Text] [Related]
19. Regulation of bone development and extracellular matrix protein genes by RUNX2.
Komori T
Cell Tissue Res; 2010 Jan; 339(1):189-95. PubMed ID: 19649655
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]